Advertisement
U.S. Markets closed

Valneva SE (AYJ.DE)

XETRA - XETRA Delayed Price. Currency in EUR
2.6660+0.1200 (+4.71%)
At close: 05:35PM CEST
Full screen
Previous Close2.5460
Open2.5640
Bid0.0000 x N/A
Ask0.0000 x N/A
Day's Range2.5640 - 2.6740
52 Week Range2.4700 - 7.0340
Volume14,960
Avg. Volume9,135
Market Cap432.3M
Beta (5Y Monthly)0.99
PE Ratio (TTM)N/A
EPS (TTM)-0.2400
Earnings DateNov 07, 2024
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • GlobeNewswire

    Valneva and LimmaTech Awarded FDA Fast Track Designation for Tetravalent Shigella Vaccine Candidate S4V

    Saint Herblain (France) and Schlieren (Zurich), October 16, 2024 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, and LimmaTech Biologics AG, a clinical-stage biotech company developing vaccines for the prevention of life-threatening diseases, announced today that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to Shigella4V (S4V), the world’s most clinically advanced tetravalent bioconjugate shigellosis vaccine candidate, for which Va

  • Simply Wall St.

    High Growth Tech Stocks In France October 2024

    As the French market navigates through a period of heightened caution due to escalating Middle East tensions and broader European economic concerns, the CAC 40 Index has experienced a notable decline. In this environment, identifying high-growth tech stocks in France requires an understanding of companies that can demonstrate resilience and adaptability amidst geopolitical uncertainties and shifting economic landscapes.